Iceland has a unique genetic profile. The population was founded by Norse settlers around 870 CE. Over 1,000 years of geographic isolation (an island in the North Atlantic), the population experienced:
This created a genetic homogeneity and traceable ancestry unmatched in Europe. If you wanted to study the genetics of disease in a population, Iceland was ideal: uniform background, detailed family history, isolated lineage.
In 1996, deCODE Genetics was founded by Kári Stefánsson, an Icelandic neuroscientist. The company proposed:
The Icelandic government granted deCODE a health sector license in 1998, giving the company access to:
In exchange, deCODE would:
It was framed as a partnership between a biotech company and a nation. It was actually a transfer of the nation's genetic heritage to a private entity.
The license triggered Icelandic opposition:
Argument 1: Consent The database included genetic and medical information from the entire nation. The government granted deCODE access without explicit individual consent—it was presumed consent based on use of the health system. Critics argued this violated informed consent principles. No individual could opt out; non-participation meant being excluded from the health database.
Argument 2: Commercialization of genetic heritage Icelanders had not "agreed" to commercialize their genetic material. The genetic code was a shared national resource, not property to be licensed to a company. Gene patents would enrich deCODE and foreign pharmaceutical companies while Icelanders had no control over how their genetic information was used.
Argument 3: National sovereignty The genetic database was arguably Iceland's deepest national resource—a complete genetic map of the nation. Licensing it to a private company (even with government oversight) amounted to selling national sovereignty. What would prevent deCODE from using the data in ways the government did not anticipate or approve?
Argument 4: Re-identification risk Even if data was "anonymized," a genetic sequence combined with genealogical records could re-identify individuals. A researcher could look up a genetic variant, cross-reference it with genealogical data, and identify the person whose DNA carried that variant. The promise of privacy was illusory.
deCODE and the Icelandic government responded with what could be called "genetic patriotism": the framing of genetic research as beneficial to Iceland itself.
Argument 1: Jobs and investment deCODE would hire Icelanders, conduct research in Iceland, and generate pharmaceutical breakthroughs that would make Iceland a leader in biotech.
Argument 2: Medical benefit The research would identify disease variants specific to Icelandic populations, enabling targeted medicine and treatment.
Argument 3: National pride Iceland's unique genetic history could be the foundation of a world-leading biotech industry. The nation could export its genetic knowledge.
This framing appealed to Icelandic nationalism. The debate became not about ethics but about whether Iceland wanted to be a "modern nation" (partnering in global biotech) or a "backwater" (refusing to commercialize its resources).
By 2003, the Icelandic opposition had grown enough to force changes:
These changes addressed the consent issue slightly but not fundamentally. The genetic material was still being sequenced, patented, and commercialized.
The practical outcome:
deCODE made significant discoveries:
These discoveries were patented. Some patents were licensed to pharmaceutical companies. Some research was published. Some research was kept proprietary.
The Icelandic government did receive revenue, but it was modest compared to the value of the genetic database. The company went public, enriching investors. Icelanders received some medical benefit (certain variants were identified as relevant to Icelandic populations), but the primary beneficiaries were shareholders and pharmaceutical companies, not the Icelandic people.
The Franklin Expedition and the Iceland deCODE story sit at opposite ends of a spectrum of resource extraction:
Franklin: external exploration of a known geographic area (the Arctic). The resource being extracted is territorial—the route through the Arctic Passage.
deCODE: internal colonization of a population's genetic heritage. The resource being extracted is the population's own biological code, reframed as property to be patented and commercialized.
In both cases, the framing of the resource determines who benefits:
The Icelandic government, by licensing the genetic database to deCODE, adopted the framing that Icelandic genetics were exploitable resources. They did not adopt the alternative framing: that genetic information is a commons, that it belongs to the people who carry it, that it cannot be patented because it is not an invention.
Anthropology: Colonialism & Resource Extraction — deCODE Genetics illustrates a modern form of colonialism: not territorial conquest but genetic extraction. The logic is identical to 19th-century resource extraction: identify a resource a population has, convince the population that commercializing it is "progress," extract the resource, enrich external investors, leave the population with minimal benefit. The difference is that genetic material is renewable from the population and replicates indefinitely, so the extraction is permanent.
History: Franklin Expedition — Both narratives involve external parties claiming ownership of resources that belong to a population. The Franklin Expedition claimed the Arctic Passage. deCODE claimed the genetic code. The scale and mechanism differ, but the underlying logic is identical: external investors + population resources = ownership transfer + population receives payment while losing control.
The Sharpest Implication: The deCODE case demonstrates that in the modern biotech era, a population's greatest resource is no longer its territory but its genetics. Iceland sold access to its genetic code on the assumption it was selling knowledge (gene sequences) rather than selling sovereignty (control over who could patent and commercialize its biological information). Once the patents were granted, Icelanders had permanently lost control over how their own genetic information could be used. The decision to license the database created a permanent disadvantage: future discoveries using the Icelandic genetic code would be patented and owned by whoever made them, not by the population that carried the code.
Generative Questions: